Risk of H5N1 combining with seasonal flu to create a more dangerous pathogen increases five-fold this winter
Published by Airfinity
Oct 11, 2024
press releases
Cost of Wegovy to prevent one stroke in the US is double what’s paid by Britain’s health service
Published by Airfinity
Sep 20, 2024
press releases
Airfinity US RSV vaccine market estimate cut by 64% from $4.7bn to $1.7bn a year by 2030 following recommendations for single lifetime shot for elderly people
Published by Airfinity
Jul 24, 2024
press releases
Global surge in infectious diseases as over 40 countries report outbreaks 10-fold over pre-pandemic levels
Published by Airfinity
Jun 14, 2024
press releases
Democracies are better at managing pandemics than autocracies, according to a new study by Airfinity
Published by Airfinity
May 15, 2024
press releases
Airfinity launches obesity intelligence solution to forecast and simulate obesity related outcomes
Published by Airfinity
Jan 24, 2024
press releases
Stockpiles worth $1.1 billion of COVID-19 antiviral pill Paxlovid have expired in UK and Europe
Published by Airfinity
Jan 1, 2024
press releases
Airfinity upgrades global biorisk platform
Published by Airfinity
Dec 6, 2023
press releases
Airfinity wins Financial Times’ Tech Champions 2023
Published by Airfinity
Nov 15, 2023
press releases
Airfinity named among Bloomberg’s UK Startups to Watch 2023
Published by Airfinity
Oct 24, 2023
press releases
Airfinity appoints first Chief Medical Officer as part of increased pre-emptive health investments
Published by Airfinity
Oct 19, 2023
press releases
France could see local dengue cases rise 50-fold by 2030 as temperatures rise
Published by Airfinity
Oct 18, 2023
press releases
‘Tripledemic’ peak in US and UK hospitalisations to be smaller than last year as new COVID waves start in both countries
Published by Airfinity
Sep 6, 2023
press releases
Wegovy costs $1.3m to prevent one heart attack, stroke, or cardiovascular death
Published by Airfinity
Aug 30, 2023
press releases
Elderly RSV vaccines to generate $10.5B annually by 2030 in G7 countries
Published by Airfinity
Aug 11, 2023
press releases
China’s second COVID-19 wave to be smaller than its first peaking at 11 million cases a week, predicts Airfinity
Published by Airfinity
Jun 7, 2023
press releases
A strong pandemic defence system could reduce the chance of another COVID like pandemic in the next ten years from 27.5% to 8%
Published by Airfinity
Apr 13, 2023
press releases
Airfinity launches new platform IDA to track all infectious disease vaccine and treatment candidates
Published by Airfinity
Feb 8, 2023
press releases
China to see one longer, more severe COVID wave as Lunar Festival fuels outbreak
Published by Airfinity
Jan 17, 2023
press releases
China’s COVID-19 wave forecast to have two peaks where cases could reach 4.2 million a day
Published by Airfinity
Dec 21, 2022
press releases
China risks between 1.3 and 2.1 million deaths if it ends its zero-COVID strategy
Published by Airfinity
Nov 28, 2022
press releases
COVID-19 vaccine makers raise prices to off set falling revenue as demand for jabs drops
Published by Airfinity
Oct 17, 2022
press releases
COVID-19 and flu ‘Twindemic’ could overwhelm hospitals this winter
Published by Airfinity
Sep 30, 2022
press releases
AstraZeneca’s infant RSV drug Beyfortus could generate $1.1bn sales revenue
Published by Airfinity
Sep 16, 2022
press releases
18 million monkeypox vaccines needed to protect most at risk, 85 million to protect wider gay community and health workers
Published by Airfinity
Aug 25, 2022
press releases
AstraZeneca and Pfizer/BioNTech saved over 12 million lives in the first year of vaccination
Published by Airfinity
Jul 13, 2022
press releases
Sales of COVID-19 antiviral pill Paxlovid to leap frog Merck’s competitor Molnupiravir
Published by Airfinity
Jul 25, 2022
press releases
COVID-19 vaccines sales to bounce back with new jabs taking a fifth of the 2022 market
Published by Airfinity
Jul 15, 2022
press releases
Global wastage of COVID-19 vaccines could be 1.1 billion doses
Published by Airfinity
Jul 11, 2022
press releases
Global sales estimate for COVID-19 antiviral pills increased by 60% to $32.5bn
Published by Airfinity
Apr 22, 2022
press releases
Airfinity downgrades its global COVID-19 vaccine revenue forecast to $64.1B
Published by Airfinity
Apr 11, 2022
press releases
Global Press Release: Pfizer and Merck to generate $19.5 billion in global sales of new antiviral pills
Published by Airfinity
Dec 16, 2021
press releases
Global Press Release: China risks over a million deaths if Omicron spreads, but available Western vaccines can prevent this
Published by Airfinity
Mar 22, 2022
press releases
COVID-19 vaccine market forecast to grow 29% to $84.9B in 2022, according to Airfinity
Published by Airfinity
Jan 21, 2022
press releases
240 million COVID-19 vaccines set to expire by March, according to analysis by Airfinity
Published by Airfinity
Jan 13, 2022
press releases
Sinovac is the most used vaccine in the world, with 943m doses delivered
Published by Airfinity
Jul 7, 2021
press releases
Airfinity forecasts fewer doses to be delivered this year than COVAX
Published by Airfinity
Jul 21, 2021
press releases
Global sales of non-Chinese COVID vaccines will almost double in 2022
Published by Airfinity
Aug 4, 2021
press releases
101 countries will not meet any of the WHO targets by September
Published by Airfinity
Aug 4, 2021
press releases
GLOBAL PRESS RELEASE: More than a billion available stock of Western COVID-19 vaccines by the end of 2021
Published by Airfinity
Sep 5, 2021
press releases
More than 100 million vaccines are set to expire by the end of the year and need to be redistributed immediately
Published by Airfinity
Sep 20, 2021
press releases
UK hospitals could be overwhelmed by COVID and flu cases, potentially leading to further restrictions
Published by Airfinity
Oct 27, 2021
press releases
Airfinity and The St. Gallen Endowment launch thought leadership report